Neurology & Autoimmune Research

Multiple Sclerosis Clinical Research

Multiple Sclerosis (MS) is a chronic neurological disease that affects the central nervous system and impacts millions worldwide. CenExel partners with sponsors to advance innovative therapies through specialized clinical research focused on improving patient outcomes, slowing disease progression, and enhancing quality of life.

Studies Conducted
0 +
Trial Participants
0 +
Active Centers
0
Overview

Advancing Multiple Sclerosis Research

CenExel supports comprehensive Multiple Sclerosis clinical trials through experienced investigators, advanced operational capabilities, and access to diverse patient populations. Our research teams are committed to accelerating treatment innovation across relapsing-remitting MS, progressive MS, and related neurological conditions.

Improve Patient Outcomes

Our specialized neurology research teams help deliver patient-focused studies with efficient recruitment and high-quality data collection.

Accelerate Clinical Development

We support sponsors with operational excellence, scientific expertise, and scalable research solutions across all trial phases.
Conditions Covered

Multiple Sclerosis Conditions We Research

Our MS research programs support a broad range of neurological and autoimmune conditions.

  • Relapsing-Remitting MS (RRMS)
  • Secondary Progressive MS (SPMS)
  • Primary Progressive MS (PPMS)
  • Clinically Isolated Syndrome (CIS)
  • Neuromyelitis Optica (NMO)
  • Cognitive Impairment in MS
  • MS-Related Fatigue
  • Neuropathic Pain
Our Approach

Why Sponsors Choose CenExel for MS Research

CenExel delivers specialized neurological research expertise, efficient enrollment strategies, and operational excellence for Multiple Sclerosis clinical studies.

01

Expert Neurology Teams

Our experienced investigators and coordinators specialize in neurological and autoimmune disorders.

02

Biomarker & Imaging Support

Advanced imaging capabilities and biomarker strategies help improve study precision and outcomes.

03

Diverse Patient Access

Our nationwide site network enables access to diverse MS patient populations.

04

End-to-End Trial Support

From first-in-human studies to Phase IV programs, CenExel provides full clinical trial support.

Phase Coverage

Supported MS Trial Phases

CenExel supports early and late-phase neurological research programs across Multiple Sclerosis and autoimmune disorders.

Active across all phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Our research infrastructure supports biomarker-driven studies, imaging-based endpoints, and long-term patient follow-up strategies for MS clinical development.

Let’s Advance Your Next Study

Looking for an experienced clinical research partner with the expertise, capabilities, and reach to move your study forward? Connect with CenExel to discuss your needs and explore how our network can support your clinical development goals.

Explore Our Network

Discover CenExel’s Centers of Excellence and find the locations, therapeutic expertise, and capabilities that align with your clinical development needs.

Our Blog